Madison, Wis. – Stratatech Corp. has announced the successful completion of a clinical trial of its StrataGraft human skin substitute.
The University of Wisconsin-Madison’s Michael J. Schurr was the trial’s principal clinical investigator.
Office of Strategic Communication